ATC code B02

Last updated

ATCcodeB02Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] Subgroup B02 is part of the anatomical group B Blood and blood forming organs. [4]

Contents

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB02. [5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B02A Antifibrinolytics

B02AA Amino acids

B02AA01 Aminocaproic acid
B02AA02 Tranexamic acid
B02AA03 Aminomethylbenzoic acid

B02AB Proteinase inhibitors

B02AB01 Aprotinin
B02AB02 Alfa1 antitrypsin
B02AB04 Camostat
B02AB05 Ulinastatin

B02B Vitamin K and other hemostatics

B02BA Vitamin K

B02BA01 Phytomenadione
B02BA02 Menadione

B02BB Fibrinogen

B02BB01 Human fibrinogen

B02BC Local hemostatics

B02BC01 Absorbable gelatin sponge
B02BC02 Oxidized cellulose
B02BC03 Tetragalacturonic acid hydroxymethylester
B02BC05 Adrenalone
B02BC06 Thrombin
B02BC07 Collagen
B02BC08 Calcium alginate
B02BC09 Epinephrine
B02BC30 Combinations; e.g. Fibrin glue

B02BD Blood coagulation factors

B02BD01 Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)
B02BD02 Coagulation factor VIII
B02BD03 Factor VIII inhibitor bypassing activity
B02BD04 Coagulation factor IX
B02BD05 Coagulation factor VII
B02BD06 von Willebrand factor and coagulation factor VIII in combination
B02BD07 Coagulation factor XIII
B02BD08 Coagulation factor VIIa
B02BD10 von Willebrand factor
B02BD11 Catridecacog
B02BD13 Coagulation factor X
B02BD14 Susoctocog alfa
B02BD15 Valoctocogene roxaparvovec
B02BD16 Etranacogene dezaparvovec
B02BD17 Fidanacogene elaparvovec
B02BD30 Thrombin

B02BX Other systemic hemostatics

B02BX01 Etamsylate
B02BX02 Carbazochrome
B02BX03 Batroxobin
B02BX04 Romiplostim
B02BX05 Eltrombopag
B02BX06 Emicizumab
B02BX07 Lusutrombopag
B02BX08 Avatrombopag
B02BX09 Fostamatinib
B02BX10 Concizumab
B02BX11 Marstacimab

Related Research Articles

ATC code A05Bile and liver therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A05 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A09Digestives, including enzymes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A09 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A11Vitamins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A11 is part of the anatomical group A Alimentary tract and metabolism.

ATC code C04Peripheral vasodilators is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C04 is part of the anatomical group C Cardiovascular system.

ATC code D01Antifungals for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D01 is part of the anatomical group D Dermatologicals.

ATC code D02Emollients and protectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D02 is part of the anatomical group D Dermatologicals.

ATC code D03Preparations for treatment of wounds and ulcers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D03 is part of the anatomical group D Dermatologicals.

ATC code D05Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D05 is part of the anatomical group D Dermatologicals.

ATC code D09Medicated dressings is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D09 is part of the anatomical group D Dermatologicals.

ATC code D10Anti-acne preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D10 is part of the anatomical group D Dermatologicals.

ATC code D11Other dermatological preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D11 is part of the anatomical group D Dermatologicals.

ATC code G01Gynecological antiinfectives and antiseptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup G01 is part of the anatomical group G Genito-urinary system and sex hormones.

ATC code M02Topical products for joint and muscular pain is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M02 is part of the anatomical group M Musculo-skeletal system.

ATC code M05Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M05 is part of the anatomical group M Musculo-skeletal system.

ATC code M09Other drugs for disorders of the musculo-skeletal system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M09 is part of the anatomical group M Musculo-skeletal system.

ATC code N03Antiepileptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N03 is part of the anatomical group N Nervous system.

ATC code S02Otologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup S02 is part of the anatomical group S Sensory organs.

ATC code V04Diagnostic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup V04 is part of the anatomical group V Various.

ATC code V08Contrast media is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup V08 is part of the anatomical group V Various.

ATC code V10Therapeutic radiopharmaceuticals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup V10 is part of the anatomical group V Various.

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health . Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code B02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QB02". WHO Collaborating Centre for Drug Statistics Methodology.